Compare Natera Inc. Common Stock (NTRA) vs Invesco Solar ETF (TAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Invesco Solar ETF — how do they compare? Natera Inc. Common Stock trades at $392.78 (market cap $57.03B), while Invesco Solar ETF trades at $42 (market cap $888.21M). The key difference: Natera Inc. Common Stock is far larger — about 64.2× Invesco Solar ETF's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Invesco Solar ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Invesco Solar ETF for 35 Days on average.
| NTRA | TAN | |
|---|---|---|
Market Cap | $57.03B | $888.21M |
Volume | 1,131,157 | 1,632,793 |
Sector | Health | Sector/Thematic |
52-Week High | $425.64 | $73.95 |
52-Week Low | $179.42 | $42.64 |
Typical Hold Time | 0 Days | 35 Days |
Enterprise Value | $56.18B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
TAN (Invesco Solar ETF) trades at $44.38, up 2.07% today amid volatile solar sector conditions. Technical indicators show a bearish bias with mixed oscillators, while the ETF faces headwinds from high borrowing costs impacting project financing. Recent news highlights solar stocks under pressure despite long-term growth potential in renewable energy adoption.
The outlook remains cautious due to sector-specific challenges including interest rate sensitivity and competitive pressures. Investment opportunity exists in the long-term energy transition theme, but near-term risks include policy uncertainty and margin compression across solar manufacturers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Invesco Solar ETF
TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →
